Trial Profile
Comparison of Circadian Variability of Platelet Inhibition in Patients With Myocardial Infarction Treated With Prasugrel and Ticagrelor.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms DRAGON
- 23 Feb 2020 Status changed from recruiting to completed.
- 08 Mar 2018 New trial record